Phocas Financial Corp. Acquires Shares of 99,570 Select Medical Holdings Co. (NYSE:SEM)

Phocas Financial Corp. acquired a new stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 99,570 shares of the health services provider's stock, valued at approximately $1,877,000. Phocas Financial Corp. owned approximately 0.08% of Select Medical as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. American Century Companies Inc. raised its position in shares of Select Medical by 1,309.5% during the fourth quarter. American Century Companies Inc. now owns 137,169 shares of the health services provider's stock worth $2,586,000 after purchasing an additional 127,437 shares during the period. Sanctuary Advisors LLC grew its stake in Select Medical by 122.8% in the 4th quarter. Sanctuary Advisors LLC now owns 52,175 shares of the health services provider's stock valued at $1,035,000 after purchasing an additional 28,759 shares during the period. Sterling Capital Management LLC grew its stake in shares of Select Medical by 9.5% during the 4th quarter. Sterling Capital Management LLC now owns 11,304 shares of the health services provider's stock worth $213,000 after acquiring an additional 978 shares during the period. Vanguard Group Inc. grew its stake in shares of Select Medical by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider's stock worth $239,640,000 after acquiring an additional 131,228 shares during the period. Finally, KBC Group NV grew its stake in shares of Select Medical by 14.0% during the 4th quarter. KBC Group NV now owns 14,883 shares of the health services provider's stock worth $281,000 after acquiring an additional 1,833 shares during the period. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Stock Performance

SEM traded up $0.15 during mid-day trading on Friday, reaching $15.32. 1,458,596 shares of the company traded hands, compared to its average volume of 929,968. The stock has a market capitalization of $1.97 billion, a P/E ratio of 9.28, a P/E/G ratio of 0.64 and a beta of 1.40. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The company's fifty day moving average price is $15.91 and its 200-day moving average price is $18.79. Select Medical Holdings Co. has a 52-week low of $14.03 and a 52-week high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.01). The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.40 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company's revenue for the quarter was down 24.4% on a year-over-year basis. During the same quarter last year, the company earned $0.75 earnings per share. On average, sell-side analysts expect that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical declared that its Board of Directors has initiated a stock buyback program on Thursday, May 1st that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the health services provider to reacquire up to 42.6% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its stock is undervalued.

Select Medical Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were given a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date was Thursday, May 15th. Select Medical's dividend payout ratio (DPR) is currently 18.66%.

Insider Buying and Selling

In other Select Medical news, Director Parvinderjit S. Khanuja bought 21,000 shares of Select Medical stock in a transaction that occurred on Monday, May 5th. The stock was purchased at an average price of $15.02 per share, with a total value of $315,420.00. Following the completion of the acquisition, the director now directly owns 65,089 shares in the company, valued at approximately $977,636.78. This trade represents a 47.63% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the transaction, the chief executive officer now directly owns 714,516 shares of the company's stock, valued at approximately $12,861,288. This trade represents a 23.95% decrease in their position. The disclosure for this sale can be found here. 11.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SEM. Royal Bank of Canada dropped their price objective on Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a report on Wednesday, May 7th. Wall Street Zen raised Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. Benchmark raised Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective on the stock in a report on Monday, February 24th. Finally, Mizuho assumed coverage on Select Medical in a report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Select Medical currently has a consensus rating of "Moderate Buy" and an average price target of $26.00.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.